Literature DB >> 25664609

Targeting protein-protein interfaces using macrocyclic peptides.

Meng Gao1, Kui Cheng1, Hang Yin1,2.   

Abstract

Protein-protein interactions (PPIs) are critical in numerous biological processes including signaling transduction, function regulations, and disease development. To regulate PPIs has been thought to be challenging due to their highly dynamic and expansive interfacial areas. Nonetheless, successful examples have been reported of targeting PPIs using small molecules, peptides, and proteins. Peptides, especially macrocyclic peptides have proven to be a particularly useful tool to inhibit PPIs for their exquisite potency, stability and selectivity. Herein we review the recent developments of this area of research, focusing on the macrocyclic peptides isolated from natural products, identified from library screening, and rationally designed based on structures, as PPI regulators.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  inhibitor; macrocyclic peptide; protein−protein interface; rational design

Mesh:

Substances:

Year:  2015        PMID: 25664609      PMCID: PMC4516620          DOI: 10.1002/bip.22625

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  53 in total

Review 1.  Protein-protein interactions define specificity in signal transduction.

Authors:  T Pawson; P Nash
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions.

Authors:  Hartmuth C. Kolb; M. G. Finn; K. Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2001-06-01       Impact factor: 15.336

3.  Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53.

Authors:  C García-Echeverría; P Chène; M J Blommers; P Furet
Journal:  J Med Chem       Date:  2000-08-24       Impact factor: 7.446

Review 4.  Inferences, questions and possibilities in Toll-like receptor signalling.

Authors:  Bruce Beutler
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

Review 5.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

6.  HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.

Authors:  Peter Cherepanov; Goedele Maertens; Paul Proost; Bart Devreese; Jozef Van Beeumen; Yves Engelborghs; Erik De Clercq; Zeger Debyser
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

7.  Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp.

Authors:  S J Duncan; S Grüschow; D H Williams; C McNicholas; R Purewal; M Hajek; M Gerlitz; S Martin; S K Wrigley; M Moore
Journal:  J Am Chem Soc       Date:  2001-01-31       Impact factor: 15.419

Review 8.  TNF-R1 signaling: a beautiful pathway.

Authors:  Guoqing Chen; David V Goeddel
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

9.  The Sm-like Hfq protein increases OxyS RNA interaction with target mRNAs.

Authors:  Aixia Zhang; Karen M Wassarman; Joaquin Ortega; Alasdair C Steven; Gisela Storz
Journal:  Mol Cell       Date:  2002-01       Impact factor: 19.328

10.  Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.

Authors:  Yupeng He; Haruhisa Nakao; Seng-Lai Tan; Stephen J Polyak; Petra Neddermann; Sangeetha Vijaysri; Bertram L Jacobs; Michael G Katze
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  17 in total

1.  Rapid synthesis of cyclic oligomeric depsipeptides with positional, stereochemical, and macrocycle size distribution control.

Authors:  Suzanne M Batiste; Jeffrey N Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-14       Impact factor: 11.205

2.  Predicting bioactive conformations and binding modes of macrocycles.

Authors:  Andrew Anighoro; Antonio de la Vega de León; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2016-09-21       Impact factor: 3.686

3.  Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.

Authors:  David Hymel; Robert A Grant; Kohei Tsuji; Michael B Yaffe; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2018-08-19       Impact factor: 2.823

4.  In Silico Analysis of Peptide Macrocycle -Protein Interactions.

Authors:  Margaret M Hurley; Meagan C Small
Journal:  Methods Mol Biol       Date:  2022

5.  Cyclization and Docking Protocol for Cyclic Peptide-Protein Modeling Using HADDOCK2.4.

Authors:  Vicky Charitou; Siri C van Keulen; Alexandre M J J Bonvin
Journal:  J Chem Theory Comput       Date:  2022-06-02       Impact factor: 6.578

6.  Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins.

Authors:  Emiko Mihara; Satoshi Watanabe; Nasir K Bashiruddin; Nozomi Nakamura; Kyoko Matoba; Yumi Sano; Rumit Maini; Yizhen Yin; Katsuya Sakai; Takao Arimori; Kunio Matsumoto; Hiroaki Suga; Junichi Takagi
Journal:  Nat Commun       Date:  2021-03-09       Impact factor: 14.919

Review 7.  The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.

Authors:  Carlota Recio; Francesco Maione; Asif J Iqbal; Nicola Mascolo; Vincenzo De Feo
Journal:  Front Pharmacol       Date:  2017-01-06       Impact factor: 5.810

Review 8.  CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.

Authors:  M Michael Dcona; Benjamin L Morris; Keith C Ellis; Steven R Grossman
Journal:  Cancer Biol Ther       Date:  2017-05-22       Impact factor: 4.742

9.  Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.

Authors:  Menachem J Gunzburg; Ketav Kulkarni; Gabrielle M Watson; Nigus D Ambaye; Mark P Del Borgo; Rebecca Brandt; Stephanie C Pero; Patrick Perlmutter; Matthew C J Wilce; Jacqueline A Wilce
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

10.  Peptiderive server: derive peptide inhibitors from protein-protein interactions.

Authors:  Yuval Sedan; Orly Marcu; Sergey Lyskov; Ora Schueler-Furman
Journal:  Nucleic Acids Res       Date:  2016-05-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.